Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNatureNobel
Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma
2013
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Long‐term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus–related cirrhosis
2015
Risk Associations of Glycemic Burden and Obesity With Liver Cancer—A 10‐Year Analysis of 15,280 Patients With Type 2 Diabetes
2022
Hepatitis B Virus (HBV) Infection in Asian and Pacific Islander Americans (APIAs): How Can We Do Better for This Special Population
2008
Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
2008
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Treatment predictors of a sustained virologic response in hepatitis B and C
2008
Accuracy of Risk Scores for Patients With Chronic Hepatitis B Receiving Entecavir Treatment
2013
Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis
2013
Body Fatness and Cancer — Viewpoint of the IARC Working Group
2016 Standout
Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B
2013
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog
2012
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
2011
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
Hepatitis B: Reflections on the current approach to antiviral therapy
2008
Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up
2016
Management of Hepatic Complications in HIV‐Infected Persons
2008
Hepatitis B Virus Infection
2008
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis
2009
Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies
2012
Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection
2007
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
2008
Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years
2007
Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion
2006
Hepatitis B virus DNA levels and outcomes in chronic hepatitis B # †
2009
Telbivudine versus lamivudine and entecavir for treatment-naïve decompensated hepatitis B virus-related cirrhosis
2016
How Safe Is Moderate Alcohol Consumption in Overweight and Obese Individuals?
2016
Delivery materials for siRNA therapeutics
2013 Standout
The clinical significance of persistently normal ALT in chronic hepatitis B infection
2007
Add-On Adefovir Is Superior to a Switch to Entecavir as Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B
2011
Hepatocellular carcinoma
2012 Standout
Hepatitis B virus infection
2009 Standout
Rescue therapy for lamivudine‐resistant chronic hepatitis B: Comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add‐on lamivudine combination therapy
2010
Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
2010
Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?
2015
Prediction Models of Long-Term Cirrhosis and Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients: Risk Scores Integrating Host and Virus Profiles
2013
Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality
2016
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation
2016
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
2016
Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection
2013
Management of Hepatocellular Carcinoma: An Update Δσ
2011 Standout
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 Standout
Non-viral vectors for gene-based therapy
2014 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Non-alcoholic fatty liver disease
2021 Standout
The Epidemiology of Pancreatitis and Pancreatic Cancer
2013 Standout
Liver cancer: Approaching a personalized care
2015
Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa
2009
Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
2008
Natural history and disease progression in Chinese chronic hepatitis B patients in immune‐tolerant phase†
2007
Mediation Analysis of Hepatitis B and C in Relation to Hepatocellular Carcinoma Risk
2015
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
2015
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Chronic hepatitis B
2007 Standout
Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization
2013
Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: Meta-analysis
2013
Estimation of the Healthy Upper Limits for Serum Alanine Aminotransferase in Asian Populations With Normal Liver Histology
2009
Chronic hepatitis B: Update 2009 #
2009 Standout
Role of viral factors in the natural course and therapy of chronic hepatitis B
2007
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma
2010
Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside‐naïve HBeAg‐positive patients with chronic hepatitis B
2009
Management of HCC
2012
Comparison of the Efficacy of Lamivudine Plus Adefovir Versus Entecavir in the Treatment of Lamivudine-Resistant Chronic Hepatitis B: A Systematic Review and Meta-Analysis
2013
Predictive Factors for Reactivation of Hepatitis B Following Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B
2007
Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
2011
Entecavir Therapy for up to 96 Weeks in Patients With HBeAg-Positive Chronic Hepatitis B
2007
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNobel
Hepatitis B virus infection
2018
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B
2008
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Spontaneous relapse of hepatitis in inactive HBsAg carriers
2007
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Hepatitis B virus induces RNR-R2 expression via DNA damage response activation
2015 StandoutNobel
Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative Patients
2007
Hepatocellular Carcinoma
2011 Standout
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
2012
Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection
2013
Hepatitis B Virus Status and Risk of Pancreatic Ductal Adenocarcinoma
2011
Hepatocellular carcinoma
2022 Standout
Synergistic Effects of Family History of Hepatocellular Carcinoma and Hepatitis B Virus Infection on Risk for Incident Hepatocellular Carcinoma
2013
Treatment of HCV Infection by Targeting MicroRNA
2013 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
2010
AASLD guidelines for treatment of chronic hepatitis B
2015
High Viral Load and Hepatitis B Virus Subgenotype Ce Are Associated With Increased Risk of Hepatocellular Carcinoma
2008
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Hepatitis C Virus Seromarkers and Subsequent Risk of Hepatocellular Carcinoma: Long-Term Predictors From a Community-Based Cohort Study
2010
Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression
2016
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
2014 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B
2016
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
‘Liver let die’: oxidative DNA damage and hepatotropic viruses
2014
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Updated thresholds for serum alanine aminotransferase level in a large‐scale population study composed of 34 346 subjects
2012
Surveillance for hepatocellular carcinoma
2014
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
2007
Hepatitis B Virus Replication and Liver Disease Progression: The Impact of Antiviral Therapy
2006
Global cancer statistics, 2012
2015 Standout
Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis
2015
Nonalcoholic Fatty Liver Disease
2015 Standout
Factors influencing liver disease progression in chronic hepatitis B
2006
Works of Jun Su being referenced
Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection
2010
Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma
2011
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
2006
Risk and Predictors of Mortality Associated With Chronic Hepatitis B Infection
2007
Synergism Between Obesity and Alcohol in Increasing the Risk of Hepatocellular Carcinoma: A Prospective Cohort Study
2013
The impact of hepatitis C virus infection on work absence, productivity, and healthcare benefit costs†
2010
Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study
2009
Incidence and Determinants of Spontaneous Seroclearance of Hepatitis B e Antigen and DNA in Patients With Chronic Hepatitis B
2011
Obesity and Alcohol Synergize to Increase the Risk of Incident Hepatocellular Carcinoma in Men
2010
Carriers of Inactive Hepatitis B Virus Are Still at Risk for Hepatocellular Carcinoma and Liver-Related Death
2010
Lifetime Risk and Sex Difference of Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B and C
2011